Application of PARP1-Specific Pt(II)-Based Targeted Drug Conjugate in the Treatment of Ovarian Cancer by Inhibiting PARP1 and Suppressing DNA Damage Repair | Inorganic Chemistry https://t.co/AVbKFDyVl1 Gou and co-workers @InorgChem#platinum#PARP1#DNA#TDC
https://t.co/k3NFqFW59q
New Chemoimmunotherapy .. After a loooong revision process it is finally out in Advances Science :) ... Thanks for the great collaboration @WalterBerger19 and congrats to M. Gutmann.
Our work on high-throughput synthesis of triazole-based metal complexes is out now in @NatureComms!
Link for Paper and Blog Post by Postdoc David who did the bulk of the work below.
Happy to see this collaborative with Hui Chao and @Johannes_Karges out in @angew_chem. We designed Ir(III) complexes to trigger oncosis and activate the cyclic GMP–AMP synthase-stimulator of interferon genes pathway.
@ChimieParisTech
https://t.co/6dJeRKnILN
We are thrilled to see this out! 🥳🍾Check out our work on light activated ruthenium complexes to degrade NDM-1 in Gram-negative bacteria! Wonderful team effort by the group!
The final version of this manuscript was published in @J_A_C_S
Modular Access to N-SF5 Azetidines | Journal of the American Chemical Society https://t.co/m38ito4Tjy
Dual strike against superbugs & aggressive cancers! Our latest study explores water-soluble Ru(II) complex mitigating drug-resistant S. aureus & triple-negative breast cancer (TNBC) with high precision. #MetalsInMedicine#IITKanpur@Chemistry_IITK
https://t.co/73kgHV3bj7